Literature DB >> 7310759

Polymyalgia rheumatica and giant cell arteritis--a difficult diagnosis.

J G Jones, B L Hazleman.   

Abstract

This five-year study of 108 patients with giant cell arteritis and/or polymyalgia rheumatica drawn from all departments of a district general hospital emphasizes the difficulties of diagnosis. A correct diagnosis was made by the referring doctor in 33 per cent of patients and on initial attendance at hospital in 67 per cent of patients. Symptoms were present for more than three months before referral to hospital in 39 per cent of patients, and the delay before diagnosis at hospital was greater than one month in 20 per cent. Systemic illness (present in 83 per cent of cases), anaemia (33 per cent), elevated alkaline phosphatase (73 per cent) and raised immunoglobulin levels (48 per cent) caused diagnostic problems in 28 patients at primary care level and in 23 patients at hospital.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7310759      PMCID: PMC1971040     

Source DB:  PubMed          Journal:  J R Coll Gen Pract        ISSN: 0035-8797


  11 in total

1.  Giant-cell arteritis, or arteritis of the aged.

Authors:  J W PAULLEY; J P HUGHES
Journal:  Br Med J       Date:  1960-11-26

2.  A prospective study of 102 patients with the polymyalgia rheumatica syndrome.

Authors:  E N Coomes; R M Ellis; A G Kay
Journal:  Rheumatol Rehabil       Date:  1976-11

3.  Arteritis of the aged (giant cell arteritis) and fever of unexplained origin.

Authors:  M K Ghose; S Shensa; P I Lerner
Journal:  Am J Med       Date:  1976-03       Impact factor: 4.965

4.  Early symptoms of temporal arteritis.

Authors:  M J Harrison; A T Bevan
Journal:  Lancet       Date:  1967-09-23       Impact factor: 79.321

5.  Polymyalgia rheumatica -- a clinical study with particular reference to arterial disease.

Authors:  A G Mowat; B L Hazleman
Journal:  J Rheumatol       Date:  1974-06       Impact factor: 4.666

Review 6.  Giant cell arteritis: including temporal arteritis and polymyalgia rheumatica.

Authors:  C R Hamilton; W M Shelley; P A Tumulty
Journal:  Medicine (Baltimore)       Date:  1971-01       Impact factor: 1.889

7.  Temporal or giant cell arteritis.

Authors:  S P Meadows
Journal:  Proc R Soc Med       Date:  1966-04

8.  Polymyalgia rheumatica. A manifestation of systemic giant-cell arteritis.

Authors:  K R Wilske; L A Healey
Journal:  Ann Intern Med       Date:  1967-01       Impact factor: 25.391

9.  Hepatitis-B antibody in polymyalgia Rheumatica.

Authors:  P A Bacon; S M Doherty; A J Zuckerman
Journal:  Lancet       Date:  1975-09-13       Impact factor: 79.321

10.  Prognosis and management of polymyalgia rheumatica.

Authors:  J G Jones; B L Hazleman
Journal:  Ann Rheum Dis       Date:  1981-02       Impact factor: 19.103

View more
  3 in total

1.  ESR in polymyalgia rheumatica and giant cell arteritis.

Authors:  J G Jones; B L Hazleman
Journal:  Ann Rheum Dis       Date:  1983-12       Impact factor: 19.103

2.  Polymyalgia rheumatica: a general practice experience.

Authors:  R M Turner
Journal:  J R Coll Gen Pract       Date:  1983-03

3.  Abnormal radionuclide liver scans in giant cell arteritis.

Authors:  J Jones; M V Kyle; B L Hazleman; P Wraight
Journal:  Ann Rheum Dis       Date:  1984-08       Impact factor: 19.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.